Ally Bridge Group
  • About
  • Strategies
  • Team
  • Investments
  • News
  • Contact
  • Investor Login
    • Private Equity
      • Citco One
      • State Street Global Services
    • Public Equity

Private Equity Portfolio News: Epicrispr Biotechnologies Secures $68 Million Series B to Initiate Clinical Trial for First-in-Class Disease-Modifying Epigenetic Neuromuscular Therapy for FSHD

Financing led by Ally Bridge Group, with participation from SOLVE FSHD, a venture philanthropy organization Lead program, EPI-321, is the first clinical application of epigenetic modulation in neuromuscular diseases, with…

Private Equity Portfolio News: Cardiac Dimensions Raises $53 Million Series E Financing

To fund completion of the EMPOWER Trial U.S. pivotal study and continue the commercialization of the Carillon Mitral Contour System KIRKLAND, WA—Cardiac Dimensions®, a leader in minimally invasive treatments for…

Private Equity Portfolio News: VitalConnect, Inc. Secures $100 Million in Financing

Latest Funding Accelerates the Company’s Commercial Expansion SAN JOSE, CA—VitalConnect®, Inc., a leader in biosensor technology, specializing in ambulatory cardiac monitoring, today announced the closing of $100 million in financing…

Private Equity Portfolio News: Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing

Aadi Enters into Exclusive License for Three-Asset ADC Portfolio Developed through a Collaboration between WuXi Biologics and HANGZHOU DAC Aadi Enters Agreement to Sell FYARRO® and Associated Infrastructure to KAKEN…

Late-Stage Investors Seek to Bring Medtech Startups to the Home Stretch

Medical-device companies are raising big venture rounds to fortify their business and position themselves for a strong public offering or sale Venture investors are writing large checks to maturing medical-device…

Private Equity Portfolio News: Imperative Care Completes Initial Closing of Series E Financing for up to $150 Million; Shacey Petrovic Appointed to Vice Chair, Board of Directors

Financing Fuels the Company’s Hypergrowth to Make Elevated Care Accessible to More Patients. Petrovic’s Appointment Positions Imperative Care for Long Term Success and Scale. CAMPBELL, CA—(BUSINESS WIRE)—Imperative Care, Inc., a…

Private Equity Portfolio News: Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round

Kestra Medical Technologies, Inc. announced today an oversubscribed $196 million funding round to support the expansion of their commercial organization and advance its mission of protecting at-risk patients with its…

Private Equity Portfolio News: Insightec Announces $150M Financing to Fund Continued Growth

Fidelity Management & Research Company Leads Financing; Nexus Neurotech Ventures and Ally Bridge Group Co-Lead Robust Investor Syndicate. FOR IMMEDIATE RELEASE: HAIFA, ISRAEL AND MIAMI, FL—Insightec, a global healthcare company…

Private Equity Portfolio News: Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines

– Proceeds will support clinical development of lead pipeline candidates: ENV-101 for fibrotic lung diseases including idiopathic pulmonary fibrosis, and ENV-501, a next-generation HER3-targeted antibody-drug conjugate, for solid tumors –…

Ally Bridge Group Announces Key Promotions and New Appointment

NEW YORK—(BUSINESS WIRE)—Ally Bridge Group (“ABG”), a leading global healthcare investment firm focused on high-impact life science innovation, today announced several key promotions within its investment team and a new…

Posts navigation

1 2 … 8
9
November